A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers

NCT05238207 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Only Part A (single dosing) was conducted due to business considerations

Conditions

Hereditary Hemochromatosis

Interventions

DRUG: BBI-001
DIETARY_SUPPLEMENT: Original Fibre Metamucil

Sponsor

Bond Biosciences